LSBCF (LakeShore Biopharma Co) Tariff Resilience Score: 4/10 (As of Jun. 26, 2026)


What is LakeShore Biopharma Co Tariff Resilience Score?

LakeShore Biopharma Co LSBCF Tariff Resilience Score is 4 as of Jun. 26, 2026. The stock has 5 warning signs investors should review. Among 1,378 Biotechnology companies, LakeShore Biopharma Co ranks better than 52.39% on this metric.

LakeShore Biopharma Co has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

LakeShore Biopharma Co has High dependency on imported raw materials and international markets. Limited pricing power and alternative suppliers increase vulnerability. Previous tariff changes have impacted costs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes LakeShore Biopharma Co might have Average Resilient.

LakeShore Biopharma Co  (OTCPK:LSBCF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

LakeShore Biopharma Co Tariff Resilience Score Related Terms

LSBCF vs ACUT, PPCB, ENSC: Tariff Resilience Score Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 4 mean?
LakeShore Biopharma Co (LSBCF) has a Tariff Resilience Score of 4 as of Jun. 26, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, LakeShore Biopharma Co ranks #656 out of 1378 companies in the Biotechnology industry, placing it in the top 47.6%.
Is LakeShore Biopharma Co's Tariff Resilience Score too high?
LakeShore Biopharma Co's current Tariff Resilience Score is 4. The Biotechnology industry median Tariff Resilience Score is 4.00. LakeShore Biopharma Co's value of 4 is 0% at this industry median. Based on the distribution chart, LakeShore Biopharma Co ranks #656 out of 1378 companies in the Biotechnology industry, which is above the industry midpoint.
How does LakeShore Biopharma Co's Tariff Resilience Score compare to ACUT and PPCB?
According to the Biotechnology industry distribution chart, LakeShore Biopharma Co ranks #656 out of 1378 companies for Tariff Resilience Score. This puts LakeShore Biopharma Co in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. LakeShore Biopharma Co's value of 4 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,378 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LakeShore Biopharma Co's current Tariff Resilience Score of 4 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LakeShore Biopharma Co's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4 and 0% at the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Tariff Resilience Score is 4 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.